CLIFFORD SWAN INVESTMENT COUNSEL LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1034642
PASADENA, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$1,434,843
-$225,471 QoQ
Shares Held
11,357
-4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#942
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. GILD ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,434,843 | 11,357 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $1,660,314 | 11,913 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,803,418 | 14,693 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,828,059 | 16,469 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,866,147 | 34,871 | Shares | Other | 2025-07-30 | |
| 2025-03-31 | $5,922,178 | 52,853 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $5,561,967 | 60,214 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,429,646 | 64,762 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,523,594 | 65,932 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $5,117,538 | 69,864 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $5,755,112 | 71,042 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,593,521 | 74,640 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,832,657 | 75,680 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,427,188 | 77,464 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $7,335,109 | 85,441 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $7,195,151 | 116,634 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,325,436 | 134,694 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $8,153,508 | 137,149 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $10,871,459 | 149,724 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,530,586 | 150,760 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $10,244,371 | 148,771 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $8,108,996 | 125,468 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,142,551 | 88,269 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,858,597 | 92,714 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $7,153,650 | 92,977 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,168,512 | 95,887 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||